Evidence map›Paper›PMID 38305674›Full record

ArticleThe Journal of antimicrobial chemotherapy2024

Modification of the penicillin-binding-protein 3 as a source of resistance to broad-spectrum cephalosporins in Escherichia coli.

Samanta Freire, Jacqueline Findlay, Eva Gruner, Vera Bruderer, Patrice Nordmann, Laurent Poirel

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Aztreonam plus ceftazidime/avibactam broth disk elution test: failure to detect Escherichia coli with PBP-3 insertions.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Review
  3. Sphingolipid-mediated vesiculation in multidrug-resistantApplied and environmental microbiology · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samanta FreireFaculty of Science and Medicine, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.
Jacqueline FindlayFaculty of Science and Medicine, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.
Eva GrunerMedica-Medizinische Laboratorien Dr F. Kaeppeli AG, Zürich, Switzerland.
Vera BrudererMedica-Medizinische Laboratorien Dr F. Kaeppeli AG, Zürich, Switzerland.
Patrice NordmannFaculty of Science and Medicine, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.
Laurent PoirelFaculty of Science and Medicine, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.ORCID 0000-0001-5160-5286
University of Fribourg · CH

Funding

University of Fribourg
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CephalosporinsEscherichia coliAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesMicrobial Sensitivity TestsPenicillin-Binding ProteinsPenicillinsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCephalosporinsPenicillin-Binding ProteinsPenicillins

Identifiers

PMID38305674
PMCPMC10984938
OpenAlexW4391463857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.